about
ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligaseARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeA genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesMutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues.Aberrant receptor-mediated Cushing's syndrome.Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses.Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumorsDual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription FactorAdrenal pathophysiology: lessons from the Carney complex.Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.Insights into the molecular biology of adrenocortical tumors.Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysioMutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.Laparoscopic adrenalectomy for adrenocortical carcinoma: a medico-surgical perspective.Genetic evaluation in primary hyperparathyroidism: What investigation? For which patients?Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.Large deletions of the PRKAR1A gene in Carney complex.DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors.DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.The Great Imitator in Endocrinology: A Painful Hypophysitis Mimicking a Pituitary Tumor.Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia.Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.Cushing's disease.Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy.The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortiHeterogeneity of skin manifestations in patients with Carney complex.18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
P50
Q24290903-CFF62A7D-B486-4F0C-970F-4CA1387D4B95Q24310286-F3212CD4-8DF7-48E9-B9CE-7AA5D03E7D39Q28245373-03F31009-2F67-455B-B943-892B2E11A652Q33570265-26CFA72C-6932-4626-B2D9-DCC74FBBA7CAQ34113281-D2E84424-1CDA-4018-A336-DFC2151A5D70Q34571810-B0B951E6-45EA-4625-978F-AE60B457296CQ34741102-E2FA0A7F-ADCD-4D67-B2CD-BA73796A8B98Q35085694-FF7F41DF-1685-46FA-9BC1-245D70F8787FQ35097654-6BCED0CC-F4BA-4E6D-A813-A74CFC7F9318Q35100928-76D99D74-ED2E-407E-BD5F-E418E5993024Q35874878-8D3B416B-682A-41F4-80FC-BCB9BD296D70Q36271643-65E1D843-877A-4A0E-B281-B214FB2C6E93Q36643559-B46719B0-63C0-4AFA-BBE7-93E323379231Q36788107-607711D0-7E3A-4B0D-8AD0-1F9E8880A4D9Q37204344-3E82235F-4C54-4E91-ADC1-EE3D81C695C5Q37212283-39F385F9-72FF-46F5-9448-634376D5635DQ37257579-72685020-D5FD-474B-87ED-3D66045F46BDQ38041783-5BBA3CCD-2BFB-4C9E-BD6B-82E336FD29A8Q38455088-4DE92185-FDD7-428D-9961-A51C24D6655EQ39802037-12F11A15-CD98-4FFC-8EBC-C27D8452119FQ40020208-BC93EC68-D9F5-4BE0-9188-C135DF3016C5Q40425821-D6A726A7-3666-4788-B70D-3852D0A57147Q40677070-89CCD1B7-4921-4102-9AD5-23259AFA38F0Q41070178-F133D7CE-0C33-439C-B949-AF9F414CFD74Q41192988-746E6825-A566-4083-9B04-13978A5E02D9Q42436641-9B2682FD-F8BB-436F-BE0C-76D4B351DBAEQ42450040-9B3D27F1-5381-45CE-9106-C3E62B8060BBQ42474931-279F73E8-6CB1-4F5F-A7D1-4E36D856B1C0Q43105668-C1D1F782-A187-4EA1-B04E-EF224D081831Q43234270-29AE2862-D6A7-4D8B-BFF9-4DA8E9625A52Q43266179-E766FC13-A5E6-408E-A179-2D51BE547F72Q43982397-DAE74E3C-FC26-4060-8FCC-CD703E197533Q44127021-42971DCA-7B10-401D-A6BE-2578809D316BQ44590623-E9DBCA9E-1CE5-44EA-B553-80575EB5003EQ44931959-0F59555E-4478-494D-95E4-0ABF174EEC5BQ45178362-916D2612-51FC-4D8B-8740-A42BEE9C8584Q45340717-D9A9639A-E8B7-4222-B38A-2301B4924430Q46135190-3FACE788-E335-4F0B-A2DA-9709C8708F03Q46410649-35E6DD5A-B9FF-4F04-90CB-61861EDFD301Q46819044-ABF39E73-E0BB-4262-B5DC-DFAF7846F378
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lionel Groussin
@ast
Lionel Groussin
@en
Lionel Groussin
@es
Lionel Groussin
@nl
Lionel Groussin
@sl
type
label
Lionel Groussin
@ast
Lionel Groussin
@en
Lionel Groussin
@es
Lionel Groussin
@nl
Lionel Groussin
@sl
prefLabel
Lionel Groussin
@ast
Lionel Groussin
@en
Lionel Groussin
@es
Lionel Groussin
@nl
Lionel Groussin
@sl
P106
P21
P31
P496
0000-0003-1476-475X
P569
2000-01-01T00:00:00Z